期刊文献+

流式细胞术分析不同分期的恶性肿瘤外周血T淋巴细胞亚群的变化 被引量:16

The change of the immunocyte in peripheral blood of the patients with cancer in different stage by FCM
下载PDF
导出
摘要 目的:研究肿瘤患者不同分期的外周血T淋巴细胞亚群的变化。方法:采用流式细胞术对36例肿瘤患者外周血T细胞及其亚群进行检测,并对不同分期患者的结果进行分析比较。结果:36例肿瘤患者CD3+T、CD+4T细胞水平均下降,Ⅳ期患者的CD+3T细胞水平与Ⅰ、Ⅱ期比较有显著性差异(P<0.05);Ⅳ期患者的CD+4T细胞水平与Ⅰ、Ⅱ期比较有非常显著性差异(P<0.01),与Ⅲ期比较亦有显著性差异(P<0.05);CD+8T细胞则随临床分期的提高略有升高,但无统计学差异;CD4+/CD8+的比值随临床分期的提高而降低,Ⅳ期患者与Ⅰ、Ⅱ期比较差异显著(P<0.05);NK细胞随临床分期提高呈现轻度降低后增加的趋势,但无统计学差异。结论:恶性肿瘤患者随着TNM分期的提高,其机体的细胞免疫功能呈现逐渐下降的趋势。 Objective:To investigate immune function of the cells in the peripheral blood who suffer from cancer in different stage. Methods:Using FCM to analyse the change of the immunocyte in peripheral blood of the 36 patients with cancer in different stage. Results:The CD:( T cells were significantly lower in the 4th stage than these in the first or second stage( P 〈 0. 05 ) ;CD4 T cells were significantly lower in the 4th stage than these in the first or second stage(P 〈 0. 01 ) , also significantly lower than the patients in the 3th stage(P 〈 0.05) ;CD8^+ T cells were upper a little whit the patients' stage grow, but no significantly different; CD4+/CD8+ was signifieantly lower with the patients' stage grow, were significantly lower in the 4th stage than these in the first or second stage(P 〈 0. 05 ; The change of the NK ceils had no regulation in different stage. Conclusion: It shows that the patients' immune function of the cells should be lower with the patients' stage of TNM grow.
作者 周晋华
出处 《临床肿瘤学杂志》 CAS 2009年第7期619-621,共3页 Chinese Clinical Oncology
关键词 恶性肿瘤 细胞免疫 流式细胞术 T细胞亚群 Malignant tumour Immune fhnction of T-cell Flow cytometry T lymphocytes subsets
  • 相关文献

参考文献7

二级参考文献59

  • 1陆云,孔宪涛,仲人前,张玲珍.CD16^+ 细胞表达与 NK活性的关系[J].中国免疫学杂志,1997,13(3):177-178. 被引量:7
  • 2胡振东,方立德,倪峰,杜建伟,陈昭明,沈佰华,李宁丽,郑泽铣,周光炎.CD8^+T 细胞与肿瘤血运转移的关系[J].肿瘤,1997,17(3):162-163. 被引量:8
  • 3Weissman IL. Develomental switches in the immune system. Cell, 1994, 76: 207-218.
  • 4Radrizzani M, Beuedetti B, Castelli C, et al. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Int J Cancer, 1991, 49: 823-830.
  • 5Hung K, Hayashi R, Lafond-Walker A, et al. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med, 1998, 188: 2357-2368.
  • 6Bell EB, Sparshott SM, Bunce C. CD4+ T-cell memory, CD45R subsets and the persistence of antigen--a unifying concept. Immunol Today, 1998, 19: 60-64.
  • 7Gause WC, Ekkens M, Nguyen D, et al. The development of CD4+ T effector cells during the type 2 immune response. Immunol Res, 1999, 20: 55-65.
  • 8Berke G. Unlocking the secrets of CTL and NK cells. Immunol Today, 1995, 16: 343-346.
  • 9李俊 李峰 吴克宁 等.恶性肿瘤患者外周血T细胞亚群的变化[J].中国肿瘤临床与康复,1998,5(4):22-22.
  • 10Fernnadez-Cruz E,woda B A,Feldman J D.Elimination of syngeneic sarcomas in rats by a subset of Tlymphocytes[J].J Exp Med,1980,152:823.

共引文献109

同被引文献184

引证文献16

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部